Generation Bio

Generation Bio P/CF

Delisted

The P/CF (Price-to-Cash-Flow Ratio) of Generation Bio (GBIO) as of Nov 10, 2026 is -0.41. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -0.68 — a change of -40.44% (higher).

P/CF

-0.41

YoY

-40.44%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Generation Bio is 2024 -0.41 . P/CF (Price-to-Cash-Flow Ratio) of Generation Bio was 2023 -0.68 . It decreases by -40.44% higher compared to the previous year.

The Generation Bio P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
-1.28 USD
Jan 1, 2019
-0.89 USD
Jan 1, 2020
-0.51 USD
Jan 1, 2021
-0.39 USD
Jan 1, 2022
-0.35 USD
Jan 1, 2023
-0.68 USD
Jan 1, 2024
-0.41 USD
The Generation Bio P/CF history
YEARP/CFYoY
-0.41-40.44%
-0.68+94.23%
-0.35-10.37%
-0.39-23.61%
-0.51-42.48%
-0.89-30.31%
-1.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Generation Bio Stock analysis

What does Generation Bio do? Generation Bio Co. is a genetic medicines company headquartered in Cambridge, Massachusetts, that focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. The firm is developing a class of gene therapy utilizing its non-viral gene therapy platform to deliver genetic payloads to a range of tissues. The company’s non-viral gene therapy platform includes its DNA construct called closed-ended DNA (ceDNA), its cell-targeted lipid nanoparticle delivery system (ctLNP) and its established, scalable capsid-free manufacturing process. The firm is engineering its gene therapies to be redosable, which enable patient titration to reach the desired therapeutic expression and to maintain efficiency in a patient’s life. The firm is a preclinical stage company and have not identified a product candidate. Generation Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Generation Bio stock

P/CF (Price-to-Cash-Flow Ratio) of Generation Bio is -0.41 in 2024.

P/CF (Price-to-Cash-Flow Ratio) of Generation Bio changed from -0.68 to -0.41, representing a -40.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Generation Bio since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Generation Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Generation Bio

All Key Metrics — Generation Bio